Skip to main content
. 2018 Feb 15;15(4):5497–5504. doi: 10.3892/ol.2018.8062

Figure 4.

Figure 4.

KIR2DL1 (CD158a) and KIR2DL3 (CD158b) in NK cells. (A) The expression of KIR2DL1 on NK cells in patients with MDS and healthy controls. (B) The percentage of KIR2DL3 on NK cells of patients with MDS and healthy controls. Cytotoxic deficiency of NK cells was revealed in patients with MDS. KIR2DL1, killer cell immunoglobulin-like receptor 2DL1; CD, cluster of differentiation; NK, natural killer; MDS, myelodysplastic syndromes.